CUMBERLAND, Md. (Ivanhoe Newswire) – September is National Prostate Cancer Awareness month. One in eight men will develop prostate cancer in their lifetime, and 35,000 men will die this year from it.

A study from Karl Landsteiner University of Health Sciences demonstrates that treatment with focused ultrasound (HIFU) effectively controls prostate cancer and maintains patients’ quality of life.

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

3. the opening of a new $7.25M Convertible Note to support the above-mentioned acquisition and the product's development. Prostate ablation is a procedure used to treat prostate cancer. During a ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with ...

Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers MENLO PARK, Calif., Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission ...